Skip navigation

Experts recommend that people under the age of 60 get the 2nd dose of AstraZeneca at the agreed time

The National Immunoprophylaxis Expert Committee recommends that the courses of vaccination with AstraZeneca that have already been started in people under the age of 60 be completed at the agreed time with the 2nd dose and that until new data becomes available vaccinations with AstraZeneca only be continued in people over the age of 60.

The National Immunoprophylaxis Expert Committee recommends that the courses of vaccination with AstraZeneca that have already been started in people under the age of 60 be completed at the agreed time with the 2nd dose and that until new data becomes available vaccinations with AstraZeneca only be continued in people over the age of 60.

It is not recommended to stop the course of vaccination once it is started, as the 2-dose vaccine provides maximum protection after the 2nd dose of the vaccine. Also, a course of vaccination that is started with one vaccine cannot be completed with another, as there are currently no data on the combination of vaccines from different manufacturers.

If a person did not develop serious health problems after the first vaccine injection, experts say there is very little chance that they could occur after the second dose. However, the Commission recommends that you keep an eye on your health for 20 days after receiving the AstraZeneca COVID-19 vaccine and that you contact a doctor immediately if you experience any of the following symptoms:

  • fever lasting more than 3 days after vaccination,
  • shortness of breath,
  • pain in your chest or abdomen,
  • swelling or coldness of the limb,
  • severe/worsening headache or blurred vision,
  • prolonged bleeding,
  • minor bruising, red or purple spots, blood blisters on the skin.

The Commission emphasized that AstraZeneca will still provide safe protection against COVID-19 for people of the age of 60 or older.

Register for vaccinating
Scroll to top